CN Patent

CN114790164B — 一种取代的异吲哚啉-1,3-二酮类pde4抑制剂及其药物用途

Assigned to Suzhou Puzheng Pharmaceutical Co ltd · Expires 2022-12-27 · 3y expired

What this patent protects

本发明涉及一种式I所示的化合物及其消旋体、立体异构体、互变异构体、同位素标记物、溶剂化物、多晶型物、酯、前药或其药学上可接受的盐，以及包含其的药物组合物，其制备方法，及其医药用途，所述式I结构如下：

USPTO Abstract

本发明涉及一种式I所示的化合物及其消旋体、立体异构体、互变异构体、同位素标记物、溶剂化物、多晶型物、酯、前药或其药学上可接受的盐，以及包含其的药物组合物，其制备方法，及其医药用途，所述式I结构如下：

Drugs covered by this patent

Patent Metadata

Patent number
CN114790164B
Jurisdiction
CN
Classification
—
Expires
2022-12-27
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Puzheng Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.